newsfilter
← Latest News
Business Wire·

Longboard Pharmaceuticals' Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community

Presenting new posters including favorable drug interaction, pharmacokinetic and pharmacodynamic data further highlighting the potential of LP352 to be a best-in-class therapy for a broad range of Developmental and